CAR T Cell: Do Benefits Still Outweigh Risks?
Despite concerns about the development of secondary T-cell malignancies due to CAR T-cell immunotherapy, experts still believed that the benefits outweigh the risks.
MDedge News
source https://www.medscape.com/s/viewarticle/car-t-cell-do-benefits-still-outweigh-risks-2024a100036l?src=rss
MDedge News
source https://www.medscape.com/s/viewarticle/car-t-cell-do-benefits-still-outweigh-risks-2024a100036l?src=rss
Comments
Post a Comment